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A b s t r a c t
Introduction: Many years of experience and refinement of existing rotational atherectomy (RA) techniques have resulted in 
improved clinical outcomes and a tendency to broaden the spectrum of RA usage.
Aim: To compare the angiographic effectiveness and periprocedural complications in patients with stable angina (SA) and acute 
myocardial infarction (AMI) treated using RA.
Material and methods: Data were prospectively collected using the Polish Cardiovascular Intervention Society national registry 
(ORPKI) on all percutaneous coronary interventions (PCIs) performed in Poland in 2015 and 2016. In total, 975 RA procedures were 
recorded out of 221,187 PCI procedures.
Results: We compared angiographic effectiveness and periprocedural complications in 530 patients with SA and 245 with AMI 
in the RA group of patients, and 60,522 patients with SA and 91,985 with AMI in the non-RA group. The overall rate of periproce-
dural complications did not differ between SA and AMI patients in the RA group (2.3% vs. 2.0%; p = 0.84), while it was lower in AMI 
patients from the RA group compared to those from the non-RA group (2.0% vs. 3.0%; p = 0.34). The percentage of patients with 
angiographic success in the RA group was similar to the non-RA group in SA patients (97.3% vs. 97.1%; p = 0.75), whereas in the 
AMI group it was significantly higher compared to the non-RA group (96.7% vs. 92.6%; p < 0.001).
Conclusions: The angiographic effectiveness of PCI with RA in patients with AMI was not worse than in patients with SA.
Key words: percutaneous coronary intervention, angioplasty, acute myocardial infarction, rotablation, periprocedural complica-
tions, angiographic effectiveness.
Introduction
Nowadays, in Europe, there is an increasing percent-
age of older patients in the general population. Due to 
that tendency, an increasing number of patients with 
heavily calcified coronary artery stenoses undergo per-
cutaneous coronary interventions (PCIs). These lesions 
are a  great challenge for successful percutaneous re-
vascularization. Prevalence of coronary calcifications in 
patients undergoing PCI was estimated at 17% to 35% 
[1]. In selected patients, rotational atherectomy (RA) 
could serve as an alternative method for coronary ar-
tery by-pass grafting (CABG) operations. In accordance 
with the wider use of RA as a result of the improvement 
outcomes and procedural techniques, the range of in-
dications also became wider [2]. We observe increased 
use of RA in acute coronary syndrome (ACS) patients 
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including selected patients with ST-segment eleva-
tion myocardial infarction (STEMI) [3]. The appearance 
of this trend is present, even though the incidence of 
acute myocardial infarctions (AMI) decreases, and this 
trend is due to the drop in STEMI prevalence, while the 
incidence of non-ST-elevation myocardial infarctions 
increases slightly (NSTEMI) [4]. So far, it has been pos-
tulated that RA is relatively contraindicated in thrombo-
genic states such as ACS, especially in STEMI patients 
[5]. The use of RA in selected patients with STEMI and 
a  patent culprit artery without thrombus blockade 
seems to be acceptable [2, 3]. 
Aim
In this study, we aimed to assess whether the peripro-
cedural complication rate and angiographic efficacy are 
poorer in patients with AMI compared to stable angina 
(SA) when treated using PCI and RA. 
Material and methods
We analyzed prospectively collected national data 
from all patients who underwent PCI in Poland between 
January 2015 and December 2016. Data on PCI practice 
in Poland were obtained from the ORPKI Polish National 
dataset, which is coordinated nationwide by the Jagiello-
nian University Medical College in cooperation with the 
AISN PTK (Association of Cardiovascular Interventions, 
Polish Cardiac Society). The ORPKI registry and RA pa-
tients were characterized in previously published studies 
[3]. In the current study, we concentrated on periproce-
dural results due to the fact that we did no collect all 
in-hospital and follow-up data following discharge. In the 
Polish National dataset, the definition of most peripro-
cedural complications is left to the discretion of the op-
erators. The baseline characteristics as well as peripro-
cedural and outcome data were collected. The decision 
to perform RA was at the operators’ discretion at each 
center according to the current European Recommen-
dations [5]. All RA procedures were performed using the 
Rotablator rotational atherectomy system. All clinical de-
cisions, such as vascular access, burr size, and treatment 
with glycoprotein IIb/IIIa inhibitors or bivalirudin were at 
the operators’ discretion. 
Statistical analysis
All continuous variables were evaluated with the 
Kolmogorov-Smirnov test for distribution. Continuous 
variables are presented as mean ± standard deviation. 
Categorical variables are presented as numeric values 
and percentages. Continuous variables were compared 
using the two-tailed Student t-test and the Mann-Whit-
ney U-test, whereas categorical variables were compared 
using the χ2 test. To identify predictors of TIMI flow 
grade 3 after PCI, univariate and multivariate analyses 
were performed. Both univariate and multivariate regres-
sion models for major adverse cardiac and cerebrovascu-
lar events (MACCE) were constructed. A model based on 
the retrograde correction method was created. Statistical 
significance was accepted at a 0.05 level of probability. 
The statistical analyses were performed using Statistica 
10.0 software (Dell Software, Inc., Round Rock, TX, USA) 
and SPSS Statistics 24 (IBM, USA).
Results
Patients’ characteristics
The overall count of patients undergoing PCI in Po-
land in 2015 and 2016 was 221,187. Among them, there 
were 975 patients who underwent PCI with RA (0.44%) 
and 220,212 patients without RA. In the RA group, there 
were 530 cases with SA at admission (54.3%), which was 
a higher percentage compared to the non-RA group with 
60,522 cases (27.5%; p < 0.001), while there were 245 
Figure 1. Subject flowchart
Rotablation (–)
n = 220,212 (99.55)
Rotablation (+)
n = 975 (0.44)
Overall group of patients undergoing PCI in Poland in 2015 and 2016
N = 221,187 (100)
STEMI 
n = 50,981 (55.42)
NSTEMI 
n = 41,004 (44.57)
STEMI
n = 133 (54.28)
NSTEMI
n = 112 (45.71)
Acute myocardial 
infarction
n = 91,985 (41.77)
Stable angina
n = 60,522 (27.48)
Acute myocardial 
infarction
n = 245 (25.12)
Stable angina
n = 530 (54.35)
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(25.1%) cases with AMI presentation of coronary artery 
disease (CAD) at admission, which was a  significantly 
lower percentage as compared to the non-RA group of 
91,985 (41.8%; p < 0.001). We also noted differences 
in the clinical presentation of CAD between the RA and 
non-RA groups. In the RA group, there was a higher per-
centage of patients with SA (530; 54.8%) compared to 
the non-RA group (60,522; 27.5%; p < 0.001), while the 
percentages of unstable angina (UA) (19.3% vs. 29.8%; 
p < 0.001), NSTEMI (11.6% vs. 18.6%; p < 0.001) and 
STEMI (13.7% vs. 23.2%; p < 0.001) patients were signifi-
cantly lower. We excluded from further analysis patients 
with symptoms of unstable angina before PCI in both 
investigated groups (Figure 1). Patients’ characteristics 
and other indices including concomitant diseases, past 
percutaneous and cardiac procedures, as well as time of 
the procedure expressed as contrast dose and radiation 
exposure are presented in Table I. 
Periprocedural complications
The rate of periprocedural complications was signifi-
cantly higher in patients treated with RA compared to 
non-RA procedures in the SA group (p = 0.003), while in 
the AMI group there was no such difference (p = 0.35). 
The incidence of individual complications in all observed 
groups is presented in Table I. 
Table I. Patients’ characteristics
Variables Overall group SA P-value AMI P-value
Rota (+) Rota (–) Rota (+) Rota (–)
Age [years] 67.1 ±10.8 71.4 ±9.2 66.9 ±9.7 < 0.001 73.1 ±10.4* 66.7 ±11.8† < 0.001
Gender, males 150,140 (67.9) 391 (73.8) 42,191 (69.7) 0.04 154 (62.8)* 62,058 (67.5) 0.12
Diabetes 52,677 (23.8) 178 (33.6) 15,828 (26.1) < 0.001 84 (34.3) 19,918 (21.6)† < 0.001
Hypertension 157,408 (71.2) 409 (77.2) 45,540 (75.2) 0.3 194 (79.2) 60,499 (65.8)† < 0.001
Past cerebral stroke 7,290 (3.3) 16 (3.1) 1,876 (3.1) 0.98 15 (6.1)* 3,289 (3.6) 0.03
Previous MI 68,955 (31.2) 280 (52.8) 25,661 (42.4) < 0.001 125 (51.0) 20,294 (22.1)† < 0.001
Previous PCI 82,444 (37.3) 345 (65.5) 33,298 (55.0) < 0.001 121 (49.4)* 20,290 (22.0)† < 0.001
Previous CABG 14,092 (6.4) 90 (17.0) 4,336 (7.2) < 0.001 29 (11.8) 3,862 (4.2)† < 0.001
Current smoker 42,574 (19.2) 79 (14.9) 9,099 (15.0) 0.93 29 (11.8) 22,195 (24.1)† < 0.001
Kidney failure 12,127 (5.5) 58 (10.9) 3,458 (5.7) < 0.001 36 (14.7) 5,088 (5.5) < 0.001
COPD 5,594 (2.5) 18 (3.4) 1,531 (2.5) 0.2 5 (2.0) 2,373 (2.6) 0.59
Complications:
Overall/patient 4,266 (1.9) 12/530 (2.3) 596 (1.0) 0.003 5/245 (2.0) 2,804 (3.0)† 0.35
Overall/complication 4,776 (2.1) 14/530 (2.6) 644 (1.1) < 0.001 6/245 (2.4) 3,384 (3.7)† 0.3
Arterial dissection 234 (0.1) 0/96 (0) 59 (0.1) 0.7 0/35 (0) 96 (0.1) 0.83
CAP 393 (0.2) 4/530 (0.7) 103 (0.2) 0.001 2/245 (0.8) 174 (0.2) 0.02
Cardiac arrest 1,413 (0.6) 3/530 (0.6) 91 (0.1) 0.01 2/245 (0.8) 1,101 (1.2)† 0.58
Death 1,018 (0.5) 0/530 (0) 24 (0.04) 0.64 0/245 (0) 842 (0.9)† 0.13
Allergic reaction 354 (0.2) 1 (0.2) 120 (0.2) 0.96 0 (0) 135 (0.1) 0.54
Cerebral stroke 18 (0.01) 0 (0) 3 (0.01) 0.84 0 (0) 12 (0.01) 0.85
Puncture-site bleeding 223 (0.1) 2 (0.4) 52 (0.08) 0.02 0 (0) 104 (0.1) 0.59 
Time of the procedure:
Radiation [mGy] 1,071.6 ±965.1 1,763.0 
±1,387.8
1,015.4 ±936.0 < 0.001 1,516.5 
±1,030.1
1,106.7 
±1,016.2†
< 0.001
Contrast [ml] 176.2 ±79.0 221.1 ±96.5 169.8 ±79.3 < 0.001 225.9 ±100.6 180.1 ±79.0† < 0.001
Data are expressed as mean ± SD or numbers (percentages). Student’s t-test or the Mann-Whitney U test was used for continuous variables, and the χ2 test was 
used for categorical variables. CABG – coronary artery bypass grafting surgery, CAP – coronary artery perforation, COPD – chronic obstructive pulmonary disease, 
MI – myocardial infarction, PCI – percutaneous coronary intervention. *p < 0.05 when SA and AMI patients were compared in the RA (+) group. †p < 0.05 when SA 
and AMI patients were compared in the RA (–) group. 
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Angiographic effectiveness and procedural 
success
The percentage of patients with thrombolysis in myo-
cardial infarction (TIMI) grade 3 flow was significantly 
higher in the non-RA group compared to the RA group 
at baseline (59.9% vs. 66.8%, p = 0.002) in SA patients, 
while it was significantly higher in the RA group com-
pared to the non-RA in AMI patients (45.8% vs. 29.2%, 
p < 0.001). The percentage of patients with TIMI grade 0 
flow at baseline was significantly lower in the AMI group 
in RA patients compared to non-RA patients (9.2% vs. 
38.3%; p < 0.001; Figure 2 A). 
Table II. Procedural indices 
Variables Overall group SA P-value AMI P-value
Rota (+) Rota (–) Rota (+) Rota (–)
Angiography:
Single-vessel disease 138,701 (69.0) 324 (72.0) 40,405 (74.0) 0.33 41 (51.9)* 51,825 (64.7)† 0.02
MVD, LMCA (–) 52,256 (26.0) 72 (16.0) 11,992 (21.9) 0.002 26 (32.9)* 23,794 (29.7)† 0.53
MVD, LMCA (+) 8,100 (4.0) 45 (10.0) 1,706 (3.1) < 0.001 10 (12.6) 3,839 (4.8)† 0.001
Isolated LMCA 1,819 (0.9) 9 (2.0) 510 (0.9) 0.02 2 (2.5)             611 (0.8) 0.07
Vascular access:
Femoral artery 56,636 (25.6) 174 (32.8) 13,604 (22.5) < 0.001 113 (46.1)* 25,277 (27.5)† < 0.001
Left radial artery 36,799 (16.6) 53 (10.0) 10,423 (17.2) < 0.001 23 (9.4) 14,604 (15.9) 0.005
Right radial artery 126,129 (57.0) 297 (56.0) 35,979 (59.4) 0.11 108 (44.1)* 51,513 (56.0)† < 0.001
Other 1,643 (0.7) 6 (1.1) 516 (0.8) 0.48 1 (0.4) 591 (0.6) 0.64
Bifurcation 11,894 (5.4) 49 (9.2) 4,058 (6.7) 0.02 14 (5.7) 4,029 (4.4)† 0.3
Chronic total occlusion 9,320 (4.2) 31 (5.8) 3,775 (6.2) 0.71 10 (4.1) 2,757 (3.0)† 0.32
Fractional flow reserve 3,258 (1.5) 9 (1.7) 2,348 (3.9) 0.009 1 (0.4) 283 (0.3)† 0.77
Intravascular ultrasound 1,882 (0.8) 24 (4.5) 976 (1.6) < 0.001 7 (2.8) 439 (0.5)† < 0.001
OCT 400 (1.8) 3 (0.6) 210 (0.3) 0.39 2 (0.8) 89 (0.1)† < 0.001
Data are expressed as numbers (percentages). Student’s t-test or the Mann-Whitney U test was used for continuous variables, and the χ2 test was used for categorical 
variables. LMCA – left main coronary artery, MVD – multi-vessel disease, OCT – optical coherence tomography. *p < 0.05 when SA and AMI patients were compared 
in the RA (+) group. †p < 0.05 when SA and AMI patients were compared in the RA (–) group. 
Figure 2. A – Distribution of TIMI flow grade (0–3) percentages before percutaneous coronary intervention in 
the overall group of patients, stable angina (RA–), stable angina (RA+), acute myocardial infarction (RA–) and 
acute myocardial infarction (RA+). B – Distribution of TIMI flow grade (0–3) percentages after percutaneous 
coronary intervention in the overall group of patients, stable angina (RA–), stable angina (RA+), acute myocar-
dial infarction (RA–) and acute myocardial infarction (RA+)
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After PCI, the percentage of patients with TIMI grade 3 
flow in the RA group was similar to the non-RA group in 
SA patients (97.3% vs. 97.1%, p = 0.75) and to the RA 
group with AMI (97.3% vs. 96.7%; p = 0.62). However, 
the percentage of patients with TIMI grade 3 flow in the 
AMI group treated with RA was higher than in the non-
RA group (96.7% vs. 92.6%; p < 0.001; Figure 2 B). We 
were not able to assess procedural success due to the 
lack of specific data. It was indirectly determined based 
on the performed type of PCI. The group of patients with 
plain old balloon angioplasty (POBA) and failed PCI could 
be considered as representing unsuccessful procedures. 
On this basis, the rate of failed RA procedures was sig-
nificantly lower in SA compared to AMI patients (1.9% 
vs. 6.9%; p < 0.001). A similar relationship was noted in 
the non-RA group when comparing SA and AMI patients 
(6.7% vs. 8.9%; p < 0.001). The frequency of POBA/failed 
PCI in the RA group was lower in this group as compared 
to the non-RA in SA and AMI groups (Table II).
Lesion characteristics
Both in the SA and AMI groups, PCI of the left main 
coronary artery (LMCA) was more often performed in the 
RA group compared to the non-RA group (p < 0.001). The 
rate of drug-eluting stent (DES) restenosis and bare-met-
al stent (BMS) restenosis was significantly lower in the 
RA group compared to the non-RA group in SA patients, 
whereas it was not significantly lower in AMI patients 
(Figure 3 A). De-novo lesions were more often treated in 
the RA group compared to the non-RA group (p < 0.001), 
while restenosis lesions were less often treated in RA pa-
tients (p < 0.001), in the SA and AMI groups (Figure 3 B). 
Location of culprit arteries is presented in Table III. 
Procedure characteristics
All procedural indices including coronary angiogra-
phy, vascular access, lesion type and additional devices 
used during the PCI are presented in Table II.
Predictors of TIMI grade 3 flow after PCI
Multivariable analysis revealed that the positive pre-
dictors of TIMI grade 3 flow after PCI in the overall group 
of patients undergoing RA included older age (odds ratio 
(OR) = 1.037; 95% confidence interval (CI): 1.029–1.045; 
p < 0.001) and patent culprit artery (TIMI grade 2 or 
3 flow) before PCI (OR = 3.76; 95% CI: 1.823–7.755; 
p < 0.001). In the SA group of patients treated with RA, 
the positive predictors of TIMI grade 3 flow after PCI also 
included older age (OR = 1.038; 95% CI: 1.027–1.049; 
p < 0.001) and patent culprit artery (TIMI grade 2 or 
3 flow) before PCI (OR = 4.169; 95% CI: 1.5–11.593; p = 
0.06). Among the positive predictors of TIMI grade 3 flow 
after PCI in patients with AMI treated with RA we also 
confirmed older age (OR = 1.035; 95% CI: 1.022–1.049; 
p < 0.001), whereas the patent culprit artery (TIMI grade 2 
or 3 flow) before PCI was only of borderline significance 
(OR = 3.691; 95% CI: 0.95–14.345; p = 0.059). 
Discussion
The main finding of the current study is that the use 
of RA in selected patients with AMI may not increase the 
periprocedural complication rate and is not associated 
Figure 3. A – Distribution of DES-, BMS-, BRS-, DCB- and POBA-restenosis percentages in the overall group 
of patients, stable angina (RA–), stable angina (RA+), acute myocardial infarction (RA–) and acute myocardial 
infarction (RA+). B – Distribution of de-novo lesion, restenosis and in-stent thrombosis percentages in the 
overall group of patients, stable angina (RA–), stable angina (RA+), acute myocardial infarction (RA–) and acute 
myocardial infarction (RA+)
BMS – bare-metal stent, BRS – bioresorbable scaffold, DCB – drug-coated balloon, DES – drug-eluting stent, POBA – plain old balloon angioplasty. 
Fr
eq
ue
nc
y 
(%
)
Fr
eq
ue
nc
y 
(%
)
100
98
96
94
92
90
100
98
96
94
92
90
10
8
6
4
2
0
10
8
6
4
2
0
 Overall SA RA (+) SA RA (–) AMI RA (+) AMI RA (–)
 count
 DES restenosis          BMS restenosis          BRS restenosis         
 DCB restenosis          POBA restenosis
 Overall SA RA (+) SA RA (–) AMI RA (+) AMI RA (–)
 count
 De-novo          Overall restenosis rate          In-stent thrombosis
A B
Rafał Januszek et al. Rotational atherectomy in patients with MI
140 Advances in Interventional Cardiology 2018; 14, 2 (52)
with poorer angiographic efficacy compared to patients 
with SA. Moreover, the angiographic success rate in pa-
tients with AMI treated with RA was higher as compared 
to patients with AMI from the non-RA group. 
Despite the fact that intra-arterial thrombus is recog-
nized as a contraindication to RA in AMI patients, espe-
cially in STEMI patients, the use of RA in this group is be-
coming more and more widespread [6]. It is associated, 
among other reasons, with the evolution of the profile 
of patients and culprit lesions in countries with well-de-
veloped networks of interventional cardiology facilities 
and frequent PCIs. Recently in these countries, STEMI 
patients more often present complex and calcified target 
lesions, they suffer from many comorbidities and are at 
increased risk of cardiac operations. Due to this, those 
patients are being transferred from the CABG group to 
the PCI with RA group more often in recent years, espe-
cially when they are unstable and regular devices are not 
able to cross well-calcified lesions. 
Periprocedural complications
Periprocedural complications typical for RA are sim-
ilar to those common for PCI and include vascular ac-
cess complications, stroke, MI, urgent CABG surgery, 
death, coronary artery perforation (CAP), artery dissec-
tion (AD), short-term closure, side branch loss and the 
slow-flow/no-reflow phenomenon [7]. The frequency of 
these periprocedural complications depends on several 
factors, with the most influential including type of PCI, 
study population and year of study [6]. In recent years, 
RA techniques have changed. Smaller burr sizing reduc-
es angiographic complications [5, 8, 9]. The incidence of 
particular complications in patients undergoing RA is 
estimated at 0–4% for death, 1–19.8% for MI, 0–0.8% 
for urgent CABG, 1.7–5.9% for CAD, 0–2% for CAP and 
0–2.6% for slow flow/no-reflow [10–12]. Complications 
typical for RA include vasospasm (1.6% to 6.6%) and burr 
entrapment (0.5% to 1%). However, a recently published 
study including a  large number of participants (13,335 
RA cases) reported that primary composite outcomes, in-
cluding in-hospital death, tamponade, and emergent sur-
gery, occurred in 1.31% of patients [13]. Most available 
publications reported predictors of periprocedural com-
plications in the overall group of patients treated with RA. 
For example, it was demonstrated that women and older 
patients were at increased risk of CAP [14]. Additional 
risk factors include the use of clopidogrel, kidney failure, 
hypertension, previous CABG, history of congestive heart 
failure including dialysis therapy, peripheral vascular dis-
ease, ACC/AHA type C lesion, radial access and multi-ves-
sel disease (MVD) [14]. Rotational atherectomy was also 
found to be an independent predictor of CAP in the overall 
group of patients undergoing PCI [3]. We presented the 
results concerning predictors of selected periprocedural 
complications in the overall group of patients treated 
with RA in a previously published study [4]. Critics of RA 
PCI focus on the high complication rates reported in older 
trials and registries. However, data reported by Sakakura 
et al. were provided in 2014 and 2015 and come from 
Japan, where interventional cardiology is recognized to 
Table III. Location of culprit lesion, type of PCI and periprocedural complications
Variable Overall group SA P-value AMI P-value
Rota (+) Rota (–) Rota (+) Rota (–)
Culprit artery:
Left main coronary 
artery
6,697 (3.2) 56 (10.6) 1,672 (3.0) < 0.001 41 (16.7)* 2,740 (3.1) < 0.001
Left anterior  
descending artery
79,411 (38.3) 226 (42.6) 20,954 (37.5) 0.01 109 (44.5) 33,606 (38.6)† 0.06
Circumflex artery 47,183 (22.7) 106 (20.0) 13,603 (24.3) 0.02 47 (19.2) 18,792 (21.6)† 0.36
Intermediate artery 3,451 (1.7) 2 (0.4) 1,041 (1.9) 0.01 3 (1.2) 1,298 (1.5)† 0.73
Right coronary artery 67,618 (32.6) 181 (34.1) 17,895 (32.0) 0.29 71 (29.0) 29,629 (34.0)† 0.09
Saphenous vein graft 2,616 (1.3) 1 (0.2) 582 (1.0) 0.05 0 (0) 940 (1.1) 0.1
Internal mammary 
artery
442 (0.2) 0 (0) 114 (0.2) 0.29 0 (0) 134 (0.1)† 0.53
Type of PCI:
Drug-eluting stent 189,553 (85.7) 507 (95.7) 52,908 (87.4) < 0.001 221 (90.2)* 77,317 (84.0)† 0.008
Bare-metal stent 7,271 (3.3) 0 (0) 1,089 (1.8) 0.002 3 (1.2)* 4,304 (4.7)† 0.01
Bioresorbable scaffold 2,934 (1.3) 3 (0.6) 1,100 (1.8) 0.03 6 (2.4)* 1,028 (1.1)† 0.04
Drug-coated balloon 4,834 (2.2) 11 (2.1) 1,477 (2.4) 0.58 2 (1.2) 1,564 (1.7)† 0.28
POBA/failed 17,249 (7.8) 10 (1.9) 4,070 (6.7) < 0.001 17 (6.9)* 8,151 (8.9)† 0.28
Data are expressed as numbers (percentages). The χ2 test was used for categorical variables. PCI – percutaneous coronary intervention, POBA – plain old balloon 
angioplasty. *p < 0.05 when SA and AMI patients were compared in the RA (+) group. †p < 0.05 when SA and AMI patients were compared in the RA (–) group. 
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be well developed [13]. Nevertheless, RA strategies in 
the past included large burr diameters, high burr speeds, 
large caliber catheters and no dual antiplatelet therapy 
or DES therapies enabling productive comparisons. Sev-
eral studies compared periprocedural complication rates 
between RA patients and non-RA patients, as well as the 
different PCI technologies. For example, Cockburn et al. 
reported that selected complications occurred more of-
ten in the RA group such as AD (3.6% vs. 2.2%; p < 0.001), 
CAP (1.1% vs. 0.3%; p < 0.001), cardiac tamponade (0.2% 
vs. 0.1%; p = 0.02), and non-Q wave MI (1.1% vs. 0.4%; 
p < 0.001) [15]. A review by Cavusoglu et al. listed the fol-
lowing complication rates: death 1%, emergency CABG 
1–2%, abrupt vessel closure 10–13%)and CAP 1.5% [7]. 
Another study completed by Kawamoto et al. included 
1,076 consecutive patients treated with RA [16]. Exclu-
sion criteria included recent STEMI and lesions with an-
giographic evidence of thrombus. The leading complica-
tion was residual AD (7.0%). CAP was observed in 1.0% 
of all cases, and 1 patient died. The rate of periprocedural 
complications was lower in the BMS group (2.6%) then in 
the DES group (2.4%) [8]. The study published by Rathore 
et al. demonstrated an acceptable in-hospital MACE rate 
(8.3%) when only considering patients receiving new-
er-generation DES following RA. In support of previous 
studies, the rate of in-hospital MACE was principally driv-
en by periprocedural MI, while the mortality rate was low 
(0.6%) [11]. Similar relationships were presented in other 
studies [12, 17]. Rotational atherectomy was used more 
frequently for LMCA intervention. The higher percentage 
of LMCA PCI shows an increased rate of patients trans-
ferred from the CABG group and higher perioperative 
risk. It could be suspected that it should worsen clinical 
and procedural outcomes in comparison to regular pa-
tients undergoing PCI. This highlights the complexity of 
many RA interventions. The higher incidence of the elec-
tive intra-aortic balloon pump procedural support in the 
RA group compared to the non-RA group could be proof 
of this [15]. One of the few published studies comparing 
the use of RA in patients with NSTEMI and SA was the 
registry published by Iannaccone et al., which included 
1,308 patients, 37% in the NSTEMI group and 63% in the 
SA group. Procedural complications were more frequent 
in the NSTEMI group compared with the SA group, driv-
en mainly by a higher rate of slow flow/no-flow (3.3% 
vs. 1.4%; p = 0.02), while in-hospital death and MACE 
did not differ significantly (1.2% vs. 0.3% and 5.7% vs. 
5.8%) [18] The largest study on RA, published by Sakak-
ura et al., demonstrated that among others well-known 
factors related to increased rate of periprocedural com-
plications such as age, gender, kidney function, num-
ber of diseased vessels, and volume of the institution, 
there was also emergent PCI, which increased the prob-
ability of composite study endpoints almost four times 
[13]. Our analysis revealed different results. It could be 
due, at least in part, to the higher rate of periprocedural 
complications in patients with unstable angina (2.7%). 
Those patients were excluded from the current analysis. 
Also, it is difficult to compare the patients’ characteris-
tics with our study, because they compared complication 
and non-complication groups, which could substantially 
blur the conclusions. The frequency of RA use in Japan is 
greater than that in Poland, which may also reflect better 
operator’s skills in performing RA procedures. Another is-
sue is that culprit lesions in AMI patients qualified for RA 
are partially prepared for PCI. The artery has to be patent 
enough for the guidewire’s passage. This, by definition, 
reduces the risk of periprocedural complications in com-
parison to regular PCI in AMI patients. 
Angiographic and procedural effectiveness
The procedural success of RA in published studies 
ranges from 72.2% to 100%. It depends on the type of PCI 
and the year of the study. The improvement in results in 
recent years is attributed to modern techniques and new 
equipment [19, 20]. For example, Benezet et al. published 
a study in a group of patients treated with RA, which in-
cluded 102 patients at the mean age of 68.8 years. The 
procedure was successful in 97% [10]. Cockburn et al. 
compared the clinical outcomes of RA and non-RA PCI 
procedures performed in the UK, which included 2,125 
patients after RA from a total of 221,669 patients under-
going PCI. Patients undergoing RA procedures were older 
(71.7 vs. 64.1 years; p < 0.001) and suffered from con-
comitant diseases more often, which was also similar in 
our group of patients. Furthermore, clinical presentation 
of CAD, vascular access and the frequencies of particu-
lar culprit arteries were similar to the results obtained in 
our study [15]. Procedural success was poorer in the RA 
group compared to the non-RA group (90.3% vs. 94.6%; 
p < 0.001) [15]. Rathore et al. compared procedural out-
comes and angiographic follow-ups in a group of 516 pa-
tients treated with RA [11]. Angiographic success (defined 
as < 30% residual stenosis and TIMI grade 3 flow) was 
achieved in 97.1% of cases. Another study reported that 
angiographic success (defined as 20% residual stenosis 
and TIMI grade 3 flow) was achieved in 96.7% of cases 
in both groups [12]. In the study published by Kawamoto 
et al., final TIMI grade 3 flow was achieved in 99.1% of 
patients even though slow- or no-flow was observed in 
1.1% [16]. In their analyses, most of the published stud-
ies compared patients treated with RA and regular PCI, or 
with a different type of stents, or stents in comparison to 
POBA. Only a few studies have compared SA with other 
clinical presentations of CAD. Iannaccone et al. reported 
that the mean post-procedure TIMI grade flow (2.9 ±0.3 
vs. 2.98 ±0.2; p = 0.058) and angio graphic success (98.8% 
vs. 99.2%, p = 0.57) were not significantly different [18]. 
However, despite the fact that the authors compared the 
NSTEMI and SA groups, the indication for RA was elec-
Rafał Januszek et al. Rotational atherectomy in patients with MI
142 Advances in Interventional Cardiology 2018; 14, 2 (52)
tive in about half of the cases in both groups (49.2% vs. 
50.9%; p = 0.73). This was different than in our population, 
where patients in the SA group were all elective, whereas 
in the STEMI group, all were urgent. It was demonstrat-
ed that vasculopathy, MVD, bifurcation lesions and low 
TIMI grade flow were among the independent predictors 
for RA in bailout cases [18]. We did not perform multi-
variable analysis of factors influencing bailout RA due to 
the fact that it would be the equivalent of AMI predic-
tors in the RA group. Similar results were obtained in the 
DART trial, which achieved a procedural success rate of 
91.6% [17]. A  more recent paper published by Benezet 
et al. reported comparable angiographic success as our data 
[10]. Tamura et al. compared BMS implantation with DES 
implantation, where angiographic success was 100% in 
both groups, while the procedural success was 96.6% and 
97.2%, respectively [19]. The high angiographic effective-
ness of RA for the STEMI group in the current study can 
certainly be attributed to the natural exclusion of patients 
with a large thrombus load and the consequent inability 
to visualize some parts of the culprit artery due to slow-
flow or no-reflow. On the other hand, STEMI patients with 
multi-segmental and calcified atherosclerosis, and who 
are more likely to undergo PCI of the LMCA and LAD, are 
at increased procedural risk at baseline. Another issue 
is that the angiographic effectiveness was higher in RA 
patients with AMI compared to procedural effectiveness. 
First, angiographic effectiveness assessed as TIMI grade 3 
flow after the procedure does not mean that the proce-
dure was effective. We are not in possession of exact data 
on procedural effectiveness. It was estimated as POBA 
and failed PCI, whereas POBA does not always mean 
that the procedure was not effective in all cases. Among 
predictors of angiographic effectiveness we found TIMI 
flow before PCI and age. While poorer TIMI flow before 
PCI could obviously impact the final effectiveness, worse 
angiographic effectiveness in younger patients remains 
unclear. Possibly, it could be explained by the low number 
of patients with impaired TIMI flow after PCI and those 
dichotomous variables could be over-fitted. 
The decision whether to perform RA or not was at the 
operators’ discretion. Definitions of periprocedural com-
plications also depended on the operators. No propensity 
score matching analysis was performed due to limited 
availability of angiographic data including calcification 
severity, vessel size, thrombus load, etc. Underreported 
periprocedural complications including periprocedur-
al myocardial infarctions and no-reflows were removed 
from the analysis. Estimation of the number of no-reflows 
in a selected group of AMI patients treated with RA is dif-
ficult and largely depends on the operator. Also, it seems 
that finally greater TIMI grade 3 flow in RA patients com-
pared to non-RA in the AMI group is substantially influ-
enced by the specific bias selection. The RA procedure 
could be performed in patients where the guidewire has 
crossed the lesion and an unsuccessful attempt of pre-
dilatation was undertaken. If the guidewire did not cross 
the culprit lesion, the operators could not use RA.
Conclusions
Rotational atherectomy used during urgent PCI in 
patients with AMI facilitates complex procedures rather 
than increasing the periprocedural complication rate or 
contributing to poorer angiographic procedural results 
when compared to the treatment of patients with SA in 
an elective manner. 
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